Petros Pharmaceuticals Inc (PTPI) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.01x

Petros Pharmaceuticals Inc (PTPI) has a Cash Flow Reinvestment Rate of 0.01x as of December 2024, reinvesting $10.90K (capex $5.45K plus investments $-5.45K) from operating cash flow of $965.40K. Explore PTPI capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.01x
(Capex + Investments) / Operating CF

Total Reinvested

$10.90K
Capex + Investments

Operating Cash Flow

$965.40K
USD

Capital Expenditures

$5.45K
USD

Petros Pharmaceuticals Inc Cash Flow Reinvestment Rate (2018–2019)

Historical reinvestment intensity for Petros Pharmaceuticals Inc across 2 annual periods. Also explore Petros Pharmaceuticals Inc assets under control for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Petros Pharmaceuticals Inc (2018–2019)

Year-by-year capital reinvestment analysis for Petros Pharmaceuticals Inc. For live market cap and broader valuation context, see PTPI market cap.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 0.06x $143.08K $2.53 Million $71.54K ▼ -75.8%
2018 0.23x $1.88 Million $8.02 Million $1.88 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow